Timing of bisphosphonate administration does not affect fracture healing or complications
Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures?J Bone Joint Surg Br. 2012 Jul;94(7):956-60
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
90 osteoporotic patients, that have undergone fixation for an intertrochanteric fracture, were randomized to receive oral administration of a bisphosphonate (Risedronate) starting either one week, one month, or three months after surgery. The results demonstrate that the timing of bisphosphonate administration following hip fracture surgery does not affect time to fracture healing or incidence of ...
Join the Conversation
Please Login or Join to leave comments.